Dr Reddy’s is claimed to be the first company in India to fully develop an in-house biogeneric, ‘Grafeel,’ (generic of biotech cancer drug Filgrastim), right from the molecular biology phase upto commercial manufacturing
Link
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment